Total planned funding: $1,342,155,082
Clear active filters
Private Contractor
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $205,471,323 |
Tanzania | $151,079,340 |
Zambia | $143,305,892 |
Kenya | $133,823,829 |
Mozambique | $109,512,607 |
Uganda | $100,057,016 |
Ethiopia | $81,976,582 |
South Africa | $81,937,039 |
Côte d'Ivoire | $79,243,952 |
Rwanda | $54,460,196 |
Zimbabwe | $48,270,383 |
Vietnam | $29,004,987 |
Haiti | $24,691,486 |
Botswana | $22,544,571 |
Namibia | $19,022,727 |
Eswatini | $9,460,669 |
Malawi | $7,468,591 |
Guyana | $6,253,749 |
Central America Region | $4,870,478 |
Ghana | $4,387,508 |
Democratic Republic of the Congo | $3,669,134 |
South Sudan | $3,512,739 |
Angola | $2,450,000 |
India | $2,448,272 |
Burundi | $2,415,862 |
Lesotho | $1,880,000 |
Russia | $1,850,000 |
Cambodia | $1,700,000 |
Indonesia | $1,560,000 |
Caribbean Region | $1,360,000 |
Ukraine | $1,300,000 |
China | $716,150 |
Cameroon | $450,000 |
Thailand | $0 |
Dominican Republic | $0 |
Central Asia Region | $0 |
Organizational Types
Private Contractor | $1,342,155,082 |
Program Areas
Treatment | $643,151,404 |
Governance and Systems | $288,308,362 |
Care | $174,882,619 |
Prevention | $167,800,809 |
Testing | $64,555,771 |
Budget Codes
HTXD: Treatment: ARV Drugs | $526,275,821 |
OHSS: Health Systems Strengthening | $146,025,609 |
HTXS: Treatment: Adult Treatment | $102,869,704 |
HLAB: Laboratory Infrastructure | $95,458,844 |
HBHC: Care: Adult Care and Support | $86,935,683 |
HVCT: Testing: HIV Testing and Counseling | $64,555,771 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $53,790,612 |
HKID: Care: Orphans and Vulnerable Children | $51,662,802 |
HVSI: Strategic Information | $46,823,909 |
HVOP: Sexual Prevention: Other Sexual Prevention | $33,962,143 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $30,179,055 |
HVTB: Care: TB/HIV | $28,943,416 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $23,073,529 |
HMIN: Biomedical Prevention: Injection Safety | $16,845,877 |
PDTX: Treatment: Pediatric Treatment | $14,005,879 |
PDCS: Care: Pediatric Care and Support | $7,340,718 |
HMBL: Biomedical Prevention: Blood Safety | $5,108,609 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $4,840,984 |
Top Partner Programs
Chemonics International:
$124,794,711
View countries